Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.3 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |